L264-1271 Screening compound: N-[5-(3-chloro-4-methoxybenzenesulfonamido)-1,3-benzothiazol-2-yl]-4-methylbenzamide

L264-1271 Screening compound: N-[5-(3-chloro-4-methoxybenzenesulfonamido)-1,3-benzothiazol-2-yl]-4-methylbenzamide
L264-1271 Screening compound: N-[5-(3-chloro-4-methoxybenzenesulfonamido)-1,3-benzothiazol-2-yl]-4-methylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L264-1271
N-[5-(3-chloro-4-methoxybenzenesulfonamido)-1,3-benzothiazol-2-yl]-4-methylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L264-1271

Molecular Formula

C22H18ClN3O4S2 (C22 H18 ClN3 O4 S2)

Compound Name

N-[5-(3-chloro-4-methoxybenzenesulfonamido)-1,3-benzothiazol-2-yl]-4-methylbenzamide

IUPAC name

N-[5-(3-chloro-4-methoxybenzenesulfonamido)-13-benzothiazol-2-yl]-4-methylbenzamide

SMILES

Cc(cc1)ccc1C(Nc1nc(cc(cc2)NS(c(cc3)cc(Cl)c3OC)(=O)=O)c2s1)=O

InChI

InChI=1S/C22H18ClN3O4S2/c1-13-3-5-14(6-4-13)21(27)25-22-24-18-11-15(7-10-20(18)31-22)26-32(28,29)16-8-9-19(30-2)17(23)12-16/h3-12,26H,1-2H3,(H,24,25,27)

InChI Key

KRJCNRNCBCIUNP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15121652

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

487.99

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.412

Distribution Coefficient, logD

5.305

Water Solubility, LogSw

-6.02

Polar Surface Area

81.371

Acid Dissociation Constant (pKa)

7.95

Base Dissociation Constant (pKb)

-1.14

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

9.10

L264-1271 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antimitotic Tubulin Library (17355 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with L264-1271 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L264-1271?
Check Price and Availability of L264-1271, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L264-1271 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L264-1271
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L264-1271
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L264-1271 available by request